Coronary Reactivity Assessment Is Associated With Lower Health Care-Associated Costs in Patients Presenting With

Ali Ahmad1,2, Michel T Corban1,3, James P Moriarty4

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (A.A., M.T.C., Y.K., R.G., C.S.R., A.P., J.D.S., L.O.L., A.L.).

Insights

Coronary reactivity testing (CRT) significantly reduced healthcare costs for patients with angina and nonobstructive coronary artery disease (ANOCA). This diagnostic approach lowers overall expenses and healthcare utilization over two years.

Area of Science:

  • Cardiology
  • Health Economics

Background:

  • Chest pain diagnosis and treatment incur substantial healthcare costs.
  • Angina and nonobstructive coronary artery disease (ANOCA) is a common condition linked to adverse cardiovascular events, repeat testing, and hospitalizations.
  • Coronary reactivity testing (CRT) can provide diagnostic certainty in ANOCA patients, but its financial impact is not well-studied.

Purpose of the Study:

  • To assess the effect of coronary reactivity testing (CRT) on healthcare-related costs in patients diagnosed with angina and nonobstructive coronary artery disease (ANOCA).

Main Methods:

  • A retrospective observational study matched ANOCA patients who underwent CRT with those who had only diagnostic coronary angiography (CAG).
  • Standardized, inflation-adjusted costs were collected and compared annually for two years post-index procedure.
  • The study included 207 patients in the CRT group and 207 in the CAG group.

Main Results:

  • The total healthcare cost was significantly higher in the CAG-only group ($37,804) compared to the CRT group ($13,679) over two years (P<0.001).
  • Major cost differences were observed in imaging (including CAG), procedures (PCI, CABG, thrombectomy), and diagnostic tests (blood tests, EKG).
  • Patients undergoing CRT demonstrated significantly reduced annual total costs and healthcare utilization.

Conclusions:

  • Coronary reactivity testing (CRT) in ANOCA patients is associated with significantly lower annual total costs and reduced healthcare utilization.
  • The findings support the potential integration of CRT into clinical practice for managing ANOCA patients.
  • CRT may offer a cost-effective diagnostic strategy for patients presenting with chest pain and nonobstructive coronary artery disease.
Abstract

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
12
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
18
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
17